M4MM
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced that its investigational ketamine implant, SP-26, met all primary endpoints in a preclinical study targeting fibromyalgia. The study, conducted in minipigs, assessed the implant's safety, ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
California’s Cannabis Excise Tax Increase Sparks Industry Concerns
LOS ANGELES- Effective July 1, 2025, California's cannabis excise tax will rise from 15% to 19%, as mandated by Assembly Bill 195 signed in 2022. This adjustment, announced by the California Department of Tax and ...
Calgary Authorizes Cannabis Sales at Adults-Only Events
LOS ANGELES- Calgary City Council has approved amendments to the Business Licence Bylaw, permitting licensed cannabis retailers to operate temporary sales at adults-only events, such as festivals and outdoor shows. This decision aligns the city's ...
Christina Lake Cannabis Closes First Tranche of Non-Brokered Private Placement
LOS ANGELES- Christina Lake Cannabis Corp. has completed the first tranche of its non-brokered private placement, issuing 22,778,211 units at a price of CAD $0.05 per unit, totaling approximately CAD $1.14 million. Each unit comprises ...
The Role of Government Relations in Cannabis Industry Success
NEW YORK — In highly regulated industries, success depends not only on how well a business operates, but also on how well it fits within the rules set by government. This is especially true in ...
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Preclinical Fibromyalgia Study
LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, announced that its investigational ketamine implant, SP-26, met all primary endpoints in a preclinical study targeting fibromyalgia. The study, conducted in minipigs, assessed the implant's safety, ...
Tilray Medical Introduces Good Supply Cannabis Brand to German Market
LOS ANGELES- Tilray Medical, a division of Tilray Brands Inc has launched its Canadian cannabis brand, Good Supply, in Germany. This expansion aims to provide German medical cannabis patients with access to a range of ...
MariMed Reports Q1 2025 Financial Results
LOS ANGELES- MariMed Inc. a multi-state cannabis operator, reported its financial results for the first quarter ended March 31, 2025. Financial Overview Revenue: $38.0 million, a slight increase from $37.9 million in Q1 2024. Gross ...
Criticism Mounts Over New York’s Social Equity Cannabis Fund for High Costs and Limited Impact
LOS ANGELES- New York’s Social Equity Cannabis Investment Fund, a public-private initiative launched to support individuals disproportionately affected by cannabis prohibition, has faced growing criticism over its high operating costs and limited results. Since its ...
Delaware Awards First Cannabis Cultivation and Manufacturing Licenses in Initial Lottery
LOS ANGELES- Delaware has initiated its adult-use cannabis licensing process, awarding the first cultivation and manufacturing permits through a lottery held on October 24, 2024. This inaugural lottery, organized by the Office of the Marijuana ...
Cybin Secures Patent for CYB005 Program in Push for New CNS Disorder Treatments
LOS ANGELES- Cybin Inc., a neuropsychiatric biopharmaceutical company, announced that it has secured a U.S. patent (No. 12,122,741) covering the composition of matter for key molecules in its CYB005 program. This patent represents a strategic ...
Unlicensed New York Cannabis Retailer Hit with $9.5 Million Judgment
LOS ANGELES- A New York Supreme Court judgment has ordered George West, owner of Jaydega 7.0 in Canandaigua, to pay $9.5 million after findings that his business sold cannabis products without the required state license. ...
Cannabis Vape Crisis Raises Key Questions About Cannabis Product Safety
LOS ANGELES — The vape contaminant crisis has significantly impacted the cannabis industry, raising crucial questions about product safety and consumer awareness. Amid this complex landscape, several industry leaders are working to address these issues ...
EU Investigates Italy’s Proposed Ban on CBD and Hemp Flowers
LOS ANGELES- The European Commission has launched an investigation into the Italian government’s proposed ban on CBD and hemp flowers, following concerns that the move may violate EU regulations. Italy's far-right government, under Prime Minister ...
South Dakota Cannabis Legalization Measure Faces Tight Race Ahead of 2024 Election
LOS ANGELES- Cannabis legalization advocates in South Dakota are facing an uphill battle ahead of the 2024 election. According to a recent Emerson College Poll, conducted in partnership with KELO-TV and *The Hill*, 50% of ...
Alabama Judge Appoints Mediator in Medical Cannabis Licensing Dispute
LOS ANGELES- A judge in Alabama has appointed a mediator to help resolve the ongoing legal dispute surrounding the state's medical cannabis licensing process. Montgomery Circuit Judge James Anderson selected retired Judge Eugene Reese to ...
Exploring the Framework: Investing in the Polish Medical Cannabis Market
EUROPE — While global attitudes toward cannabis shift from skepticism to acceptance, Poland, as a member of the European family, stands as a beacon of centuried cultivation, traditions, resilience, innovation, and economic growth. With its ...
Discovering Investment Opportunities in Italy’s Cannabis Market
EUROPE — The medical cannabis industry in Italy is undergoing a transition period, showing a significant transformation and investment potential, driven by an evolving regulatory framework and growing public acceptance. Since the legalization of medical ...
Ascend Wellness Shares Climb 5.3% Amid Low Trading Volume
LOS ANGELES- Shares of Ascend Wellness Holdings, Inc. rose by 5.3% on Friday, reaching an intraday high of $0.82 before closing at $0.80. This upward movement came despite a notable decrease in trading volume, with ...
Older Adults Increasingly Turn to Cannabis for Pain and Sleep Relief
LOS ANGELES- A growing number of older adults in the U.S. are turning to cannabis for managing sleep disturbances and chronic pain relief, especially as cannabis gains legal and social acceptance. Recent studies suggest that ...
Psyence Biomed Progresses in Psilocybin Development for Alcohol Use Disorder
LOS ANGELES- Psyence Biomed, a biopharmaceutical company focused on psychedelic therapeutics, has provided an update on its development of high-purity psilocybin in collaboration with PsyLabs. The company is working towards producing Active Pharmaceutical Ingredients (APIs) ...
What Is The Clean Label Movement: How Does It Apply To Cannabis?
LOS ANGELES — The clean label movement, which has transformed the food, beverage, and wellness industries, is also becoming a vital focus within the cannabis sector. Today’s consumers are informed, health-conscious, and increasingly demand transparency ...
Seelos Therapeutics Delisted from Nasdaq Moves to OTC Market
LOS ANGELES- Seelos Therapeutics, a clinical-stage biopharmaceutical company, has announced its delisting from the Nasdaq stock exchange after failing to meet the minimum stockholder's equity requirement. Despite an extension until October 11, 2024, granted by ...
